v3.26.1
NET LOSS PER SHARE
12 Months Ended
Dec. 31, 2025
NET LOSS PER SHARE  
NET LOSS PER SHARE

13. NET LOSS PER SHARE

Basic and diluted net loss per share for the years ended December 31, 2023, 2024 and 2025 were calculated as follows:

For the Year Ended December 31,

2023

2024

2025

  ​ ​ ​

US$

  ​ ​ ​

US$

  ​ ​ ​

US$

Numerator:

 

  ​

 

  ​

 

  ​

Net loss attributable to Adagene Inc.’s shareholders

 

(18,946,370)

 

(33,424,111)

 

(17,609,413)

Net loss attributable to ordinary shareholders

 

(18,946,370)

 

(33,424,111)

 

(17,609,413)

Denominator:

 

  ​

 

  ​

 

  ​

Weighted‑average number of ordinary shares outstanding—basic and diluted

 

54,737,530

 

56,287,903

 

59,006,129

Net Loss per share—basic and diluted

 

(0.35)

 

(0.59)

 

(0.30)

The effects of all outstanding share options, share and RSU grant, Series A Preferred Shares and warrants have been excluded from the computation of diluted loss per share for the years ended December 31, 2023, 2024 and 2025 as their effects would be anti-dilutive.

The potentially dilutive securities that have not been included in the calculation of diluted net loss per share as their inclusion would be anti-dilutive are as follows:

For the Year Ended December 31,

  ​ ​ ​

2023

  ​ ​ ​

2024

  ​ ​ ​

2025

Incremental shares on share options, share grant, RSU grant, Series A Preferred Shares and warrants

 

52,942

 

1,554,057

 

10,933,676